Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,921
datasets available to search
ShareScore release 0.9.0
Dataset results
1,921 results for “incidence”
Machine readable code lists for an algorithm to identify incident non-small cell lung cancer (NSCLC) in United States healthcare claims data
<p>Machine readable code lists for an algorithm to identify incident non-small cell lung cancer (NSCLC) in United States healthcare claims data</p>
Literature Survey of Electrostatic Incidents- Fire Protection Research Foundation report data
<p>The attached spreadsheet includes 89 incidents gathered as part of a FPRF report (report number FPRF-2021-07) "Static Electricity Incident Review" produced in August 2021. The report is available at: <a href="https://www.nfpa.org/News-and-Research/Data-research-and-tools/Electrical/Static-Electricity-Incident-Review ">https://www.nfpa.org/News-and-Research/Data-research-and-tools/Electrical/Static-Electricity-Incident-Review </a></p> <p>The incidents gathered are on electrostatic incidents found in the literature or public domain, and categorized in the following 10 columns:</p> <ol> <li>Incident Date</li> <li>Incident Location</li> <li>Incident Type</li> <li>Summary of Incident</li> <li>Potential NFPA 77 technical item that was breached</li> <li>Link/references to incident (if available)</li> <li>Number of Casualties</li> <li>Date last accessed</li> <li>Conclusions</li> <li>Why the incident happened.<br> </li> </ol>
Global-scale modeling of early factors and country-specific trajectories of COVID-19 incidence: a cross-sectional study of the first 6 months of the pandemic
<p><span>Studies examining factors responsible for COVID-19 incidence </span><span>are</span><span> mostly focused at the national or sub-national level. A global-level characterization of contributing factors and temporal trajectories of disease incidence is lacking. Here we conducted a global-scale analysis of COVID-19 infections to identify key factors associated with early disease incidence. Additionally, we compared longitudinal trends of COVID-19 incidence at a per-country level and classified countries based on COVID-19 incidence trajectories and effects of lockdown responses. </span><span>Univariate analysis identified</span> <span>eleven variables as independently associated with COVID-19 infections at a global level (p<1e-05). Multivariable analysis identified a 4-variable model as optimal for explaining global variations in COVID-19 (p<0.01). COVID-19 case trajectories for most countries were best captured by a log-logistic model, as determined by AIC estimates. Six predominant country clusters were identified when characterizing the effects of lockdown intervals on variations in COVID-19 new cases per country.</span> <span>Globally, economic and meteorological factors are important determinants of early COVID-19 incidence. Analysis of longitudinal trends and lockdown effects on COVID-19 highlights important nuances in country-specific responses to infections. These results </span><span>provide valuable insights into disease incidence at a per-country level, possibly allowing for more informed decision making by individual governments in future disease outbreaks.</span></p>
Data for "From pandemic to endemic: Spatial-temporal patterns of influenza-like-illness incidence in a Swiss canton, 1918-1924"
<p>Datasets underlying the analysis of the paper: "From pandemic to endemic: Spatial-temporal patterns of influenza incidence in a Swiss canton, 1918-1924"</p> <ul> <li><strong>Cofactors_1918.xlsx</strong> : Ecological cofactors for each bernese municipility</li> <li><strong>Data_Influenza_Bern.xlsx: </strong>Influenza data (1920-1924)</li> <li><strong>Data_Spanishflu.xlsx: </strong>"Spanish flu" data (1918-1919)</li> <li><strong>Data_Population.xlsx: </strong>Population for each municipality</li> <li><strong>Tb_death.xlsx : </strong>Number of tuberculosis death</li> <li><strong>Fabrik_Statistik_1929.xlsx : </strong>Information about the factories</li> </ul>
Incidence and influencing factors of occupational pneumoconiosis: A systematic review and meta-analysis
<p><span><strong>Objectives</strong>: </span><span>To determine the incidence of pneumoconiosis worldwide and its influencing factors. </span></p> <p><span><strong>Design</strong>:</span><span> Systematic review and meta-analysis. </span></p> <p><span><strong>Setting</strong>:</span><span> Cohort studies on occupational pneumoconiosis.</span></p> <p><span><strong>Participants</strong>:</span><span> PubMed, Embase, the Cochrane Library, and Web of Science were searched until November 2021. Studies were selected for meta-analysis if they involved at least one variable investigated as an influencing factor for the incidence of pneumoconiosis and reported either the parameters and 95% confidence intervals (CIs) of the risk fit to the data, or sufficient information to allow for the calculation of those values. </span></p> <p><span><strong>Primary outcome measures</strong>:</span><span> The </span><span>pooled incidence of pneumoconiosis and risk ratio (RR) and 95% CIs of influencing factors. </span></p> <p><span><strong>Results</strong>:</span><span> Our meta-analysis included 19 studies with a total of 335,424 participants, of whom 29,972 developed pneumoconiosis. The pooled incidence of pneumoconiosis was 0.093 (95% CI: 0.085~0.135). We identified the following influencing factors: (1) male (RR=3.74; 95%CI 1.31–10.64; P=0.01), (2) smoking (RR=1.80; 95%CI 1.34</span><span>–</span><span>2.43; P=0.0001), (3) tunneling category (RR=4.75; 95%CI 1.96</span><span>–</span><span>11.53; P<0.0001), (4) helping category (RR=0.07; 95%CI 0.13</span><span>–</span><span>0.16; P<0.0001), </span><span>(5) age (the highest incidence occurs between the ages of 50 and 60), </span><span>(6) duration of dust exposure ((RR=4.59, 95% CI 2.41</span><span>–</span><span>8.74, P<0.01), (7) cumulative total dust exposure (CTD) (RR=34.14, 95% CI 17.50</span><span>–</span><span>66.63, P<0.01). A dose-response analysis revealed a significant positive linear dose-response association between the risk of pneumoconiosis and duration of exposure and CTD (P-nonlinearity=0.10, P-nonlinearity=0.16; respectively). The Pearson correlation analysis revealed that silicosis incidence was highly correlated with CSE (r=0.794, P<0.001).</span></p> <p><span><strong>Conclusion</strong>:</span><span> The incidence of pneumoconiosis in occupational workers was 0.093 and seven factors were found to be associated with the incidence, providing some insight into the prevention of pneumoconiosis.</span></p> <p><span>PROSPERO registration number: CRD42022323233.</span></p> <p><span>Abbreviations:</span><span> NOS: Newcastle Ottawa Scale, CWP: Coal Worker's Pneumoconiosis, CTD: cumulative total dust exposure, CSE: cumulative silica exposure.</span></p>
Tracing the future of epidemics: Coincident niche distribution of host animals and disease incidence revealed climate-correlated risk shifts of main zoonotic diseases in China
<p>This dataset contains host occurrence data from NACRC database and disease incidence data for the paper "Tracing the future of epidemics: Coincident niche distribution of host animals and disease incidence revealed climate-correlated risk shifts of main zoonotic diseases in China".</p>
Understanding the incidence and timing of rabies cases in domestic animals and wildlife in south-east Tanzania in the presence of widespread domestic dog vaccination campaigns
<p>The "Zero by 30" strategic plan aims to eliminate human deaths from dog-mediated rabies by 2030, and domestic dog vaccination is a vital component of this strategic plan. In areas where domestic dog vaccination has been implemented, it is important to assess the impact of this intervention. Additionally, understanding temporal and seasonal trends in the incidence of animal rabies cases may assist in optimizing such interventions. Data on the incidence of probable rabies cases in domestic and wild animals were collected between January 2011 and December 2018 in thirteen districts of south-east Tanzania where jackals comprise over 40% of reported rabies cases. Vaccination coverage was estimated over this period, as five domestic dog vaccination campaigns took place in all thirteen districts between 2011 and 2016. Negative binomial generalized linear models were used to explore the impact of domestic dog vaccination on the annual incidence of animal rabies cases, whilst generalized additive models were used to investigate the presence of temporal and/or seasonal trends. Increases in domestic dog vaccination coverage were significantly associated with a decreased incidence of rabies cases in both domestic dogs and jackals. A 35% increase in vaccination coverage was associated with a reduction in the incidence of probable dog rabies cases of between 78.0 and 85.5% (95% confidence intervals ranged from 61.2 to 92.2%) and a reduction in the incidence of probable jackal rabies cases of between 75.3 and 91.2% (95% confidence intervals ranged from 53.0 to 96.1%). A statistically significant common seasonality was identified in the monthly incidence of probable rabies cases in both domestic dogs and jackals with the highest incidence from February to August and lowest incidence from September to January. These results align with evidence supporting the use of domestic dog vaccination as part of control strategies aimed at reducing animal rabies cases in both domestic dogs and jackals in this region. The presence of a common seasonal trend requires further investigation but may have implications for the timing of future vaccination campaigns.</p>
Blood-based epigenome-wide analyses on the prevalence and incidence of nineteen common disease states
<p>Epigenome-wide association studies (EWAS) were performed using whole-blood methylation and self-report disease data (prevalent disease) for 14 conditions at the study baseline of Generation Scotland. Furthermore, EWAS were performed on 19 incident conditions using electronic health record linkage to ascertain diagnoses following the study baseline. Basic and fully-adjusted models were considered, resulting in 66 models in total.</p> <p>medRxiv 2023.01.10.23284387; doi: https://doi.org/10.1101/2023.01.10.23284387</p>
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
ClinicalTrials.gov study NCT00056550. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overw
ClinicalTrials.gov study NCT02019264. IPD Sharing: Not stated. Countries: 8. Publications: 4.
Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease
ClinicalTrials.gov study NCT04405999. IPD Sharing: NO. Countries: 1. Publications: 1.
Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment
ClinicalTrials.gov study NCT04053699. IPD Sharing: UNDECIDED. Countries: 8. Publications: 8.
Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis
ClinicalTrials.gov study NCT05686772. IPD Sharing: NO. Countries: 1. Publications: 7.
A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease
ClinicalTrials.gov study NCT03740048. IPD Sharing: YES. Countries: 1. Publications: 24.
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men
ClinicalTrials.gov study NCT03518034. IPD Sharing: NO. Countries: 2. Publications: 6.
Evaluation of the Incidence of Cerebral Lesions Post Pulmonary Vein Ablation Catheter (PVAC)
ClinicalTrials.gov study NCT01520532. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
ClinicalTrials.gov study NCT03238911. IPD Sharing: NO. Countries: 1. Publications: 1.
Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects
ClinicalTrials.gov study NCT04217590. IPD Sharing: YES. Countries: 1. Publications: 2.
The Incidence of Venous Thromboembolism in Atopic Dermatitis
ClinicalTrials.gov study NCT04969653. IPD Sharing: YES. Countries: 1. Publications: 1.
Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients
ClinicalTrials.gov study NCT03972527. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.